Search Orphan Drug Designations and Approvals
-
Generic Name: | tbo-filgrastim |
---|---|
Date Designated: | 07/10/2017 |
Orphan Designation: | For the mobilization of peripheral blood progenitor cells (PBPCs) in healthy donors prior to allogeneic PBPC transplantation |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Sicor Biotech UAB 5 Moletu pl. 5 Vilnius, Vilniaus apskritis Lithuania The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-